
Radiation oncology priorities for clinical trials
13 May 2020

PRESS RELEASE: EORTC and ESTRO announce E2-RADIatE platform’s first site activation for Oligometastatic Disease
31 Jul 2019

EORTC and ESTRO announce a new collaboration to maximise the benefits of radiation oncology
23 Apr 2018

EORTC at ESTRO37 Congress
19 Apr 2018

Interim Results of the CATNON Study – the Effects of Temozolomide
31 Aug 2017

EORTC hosting session at ICTR-PHE 2016 in Geneva
9 Dec 2015

20-year follow-up of the academic EORTC boost no-boost trial earns Best Abstract at ECC 2015
14 Sep 2015

Can abiraterone and radiotherapy improve survival for patients with metastatic prostate cancer treated with ADT?
10 Feb 2015